Experience of application and safety assessment of the 13-valent pneumococcal conjugate vaccine in under-5 children
Author(s) -
Мarina V. Fedoseenko,
Д. А. Новикова,
Н. Е. Ткаченко,
М. И. Броева,
T. A. Grechukha,
A.G. Gaivoronskaya,
В. В. Черников
Publication year - 2014
Publication title -
педиатрическая фармакология
Language(s) - English
Resource type - Journals
eISSN - 2500-3089
pISSN - 1727-5776
DOI - 10.15690/pf.v11i5.1166
Subject(s) - pneumococcal conjugate vaccine , vaccine safety , conjugate , medicine , conjugate vaccine , virology , streptococcus pneumoniae , immunology , microbiology and biotechnology , immunogenicity , biology , immunization , antigen , mathematics , antibiotics , mathematical analysis
Author Affiliation: Marina Vladislavovna Fedoseenko, MD, senior research fellow at the vaccinal prevention department for children with medical issues at the research institute of preventive pediatrics and medical rehabilitation of the Scientific Center of Children’s Health (Federal State Budgetary Research Institution) Address: 2/62 Lomonosovskiy Av., Moscow, 119991; tel.: +7 (499) 134-20-92; e-mail: titovamarina@mail.ru
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom